Regeneron Pharmaceuticals, Inc. Logo

Regeneron Pharmaceuticals, Inc. (0R2M)

LSE

Currency in USD
836.01
+9.48 (+1.15%)

Real-time Data

07:00 AM

Day's Range

796.09
840.64

52 wk Range

541.00
857.53

Analyst Ratings - 0R2M - Regeneron Pharmaceuticals, Inc.

Analyst ratings

DateFirmActionRating
Aug 03, 2026CitigroupMaintainsNeutral
Aug 03, 2026GuggenheimMaintainsBuy
Jul 31, 2026RBC CapitalMaintainsSector Perform
Jul 31, 2026Morgan StanleyMaintainsEqual-Weight
Jul 31, 2026Cantor FitzgeraldMaintainsOverweight
Jul 31, 2026Wells FargoMaintainsEqual-Weight
Jul 31, 2026Truist SecuritiesMaintainsBuy
Jul 21, 2026GuggenheimMaintainsBuy
Jul 09, 2026Piper SandlerMaintainsOverweight
Jul 08, 2026Morgan StanleyMaintainsEqual-Weight
Items per row:

Estimates - 0R2M - Regeneron Pharmaceuticals, Inc.

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - 0R2M - Regeneron Pharmaceuticals, Inc.

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-05-15--0.53-0.61-0.08‪+15.09%‬
2026-03-13-1.511.59+0.08‪+5.30%‬
2026-01-13-1.361.52+0.16‪+11.76%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.